Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Associations of functional HLA class I groups with HIV viral load in a heterogeneous cohort

View ORCID ProfileAdrian G. Zucco, Marc Bennedbæk, View ORCID ProfileChristina Ekenberg, View ORCID ProfileMigle Gabrielaite, Preston Leung, Mark N. Polizzotto, Virginia Kan, Daniel D. Murray, Jens D. Lundgren, Cameron R. Macpherson, the INSIGHT START study group
doi: https://doi.org/10.1101/2022.06.21.22276431
Adrian G. Zucco
1PERSIMUNE Center of Excellence, Rigshospitalet, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adrian G. Zucco
  • For correspondence: adrian.gabriel.zucco@regionh.dk
Marc Bennedbæk
2Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Ekenberg
1PERSIMUNE Center of Excellence, Rigshospitalet, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christina Ekenberg
Migle Gabrielaite
3Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Migle Gabrielaite
Preston Leung
1PERSIMUNE Center of Excellence, Rigshospitalet, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark N. Polizzotto
4Clinical Hub for Interventional Research, College of Health and Medicine, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginia Kan
5George Washington University, Veterans Affairs Medical Center, Washington D.C, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel D. Murray
1PERSIMUNE Center of Excellence, Rigshospitalet, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens D. Lundgren
1PERSIMUNE Center of Excellence, Rigshospitalet, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cameron R. Macpherson
1PERSIMUNE Center of Excellence, Rigshospitalet, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Human Leucocyte Antigen (HLA) class I alleles are the main host genetic factors involved in controlling HIV-1 viral load (VL). Nevertheless, HLA diversity has proven a significant challenge in association studies. We assessed how accounting for binding affinities of HLA class I alleles to HIV-1 peptides facilitate association testing of HLA with HIV-1 VL in a heterogeneous cohort from the Strategic Timing of AntiRetroviral Treatment (START) study. We imputed HLA class I alleles from host genetic data (2,546 HIV+ participants) and sampled immunopeptidomes from 2,079 host-paired viral genomes (targeted amplicon sequencing). We predicted HLA class I binding affinities to HIV-1 and unspecific peptides, grouping alleles into functional clusters through consensus clustering. These functional HLA class I clusters were used to test associations with HIV VL. We identified four clades totalling 30 HLA alleles accounting for 11.4% variability in VL. We highlight HLA-B*57:01 and B*57:03 as functionally similar but yet overrepresented in distinct ethnic groups, showing when combined a protective association with HIV+ VL (log, β −0.25; adj. p-value < 0.05). We further demonstrate only a slight power reduction when using unspecific immunopeptidomes, facilitating the use of the inferred functional HLA groups in other studies. The outlined computational approach provides a robust and efficient way to incorporate HLA function and peptide diversity, aiding clinical association studies in heterogeneous cohorts. To facilitate access to the proposed methods and results we provide an interactive application for exploring data.

Figure
  • Download figure
  • Open in new tab

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by the Danish National Research Foundation (DNRF126) and the National Institute of Allergy and Infectious Diseases, Division of Clinical Research and Division of AIDS (National Institutes of Health grants UM1-AI068641, UM1-AI120197 and U01-AI136780). The START trial was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health Clinical Center, National Cancer Institute, National Heart, Lung, and Blood Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (France), National Health and Medical Research Council (Australia), National Research Foundation (Denmark), Bundes Ministerium fur Bildung und Forschung (Germany), European AIDS Treatment Network, Medical Research Council (United Kingdom), National Institute for Health Research, National Health Service (United Kingdom), and the University of Minnesota. Antiretroviral drugs were donated to the central drug repository by AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, Janssen Scientific Affairs, and Merck.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) gave approval for accessing the data to conduct this work. Written consent for the study and genetic analyses were obtained from the participants and ethical approval was given by site ethics review committees represented in the INSIGHT network International Coordinating Centers: The University of Minnesota -- Minneapolis, Minnesota, USA. Copenhagen HIV Programme (CHIP) -- Copenhagen, Denmark. Medical Research Council (MRC) Clinical Trials Unit -- London, United Kingdom. National Centre in HIV Epidemiology and Clinical Research (NCHECR), University of New South Wales -- Sydney, Australia. The Institute for Clinical Research at the Veterans Affairs Medical Center -- Washington, D.C., USA.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

https://persimune-health-informatics.shinyapps.io/PAW2022Zucco__HLA_HIV_INSIGHT/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 23, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Associations of functional HLA class I groups with HIV viral load in a heterogeneous cohort
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Associations of functional HLA class I groups with HIV viral load in a heterogeneous cohort
Adrian G. Zucco, Marc Bennedbæk, Christina Ekenberg, Migle Gabrielaite, Preston Leung, Mark N. Polizzotto, Virginia Kan, Daniel D. Murray, Jens D. Lundgren, Cameron R. Macpherson, the INSIGHT START study group
medRxiv 2022.06.21.22276431; doi: https://doi.org/10.1101/2022.06.21.22276431
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Associations of functional HLA class I groups with HIV viral load in a heterogeneous cohort
Adrian G. Zucco, Marc Bennedbæk, Christina Ekenberg, Migle Gabrielaite, Preston Leung, Mark N. Polizzotto, Virginia Kan, Daniel D. Murray, Jens D. Lundgren, Cameron R. Macpherson, the INSIGHT START study group
medRxiv 2022.06.21.22276431; doi: https://doi.org/10.1101/2022.06.21.22276431

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • HIV/AIDS
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9759)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2304)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1554)
  • Health Policy (733)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11635)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2140)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2173)
  • Public and Global Health (4649)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)